After a patent dispute that started in 2021, AliveCor won a recommendation for an import ban on Apple Watch sales featuring its built-in EKG functionality in the US.
However, the ban was never put in place as the Patent Trial and Appeal Board ruled that the patents in question weren’t valid.
AliveCor intended to appeal this ruling, but its appeals were rejected, meaning the Apple Watch won’t face a second import ban from the International Trade Commission.
AliveCor said it was “disappointed” by the decision and would “continue to explore all available legal options”.
The patent case is similar to one by Masimo, which was successful in getting an ITC import ban on the Apple Watch due to its use of patents over the blood oxygen sensor.
Currently, Apple Watches in the US have the blood oxygen sensor disabled.